Announcements
- Study of ovarian cancer CTCs using Parsortix
- New commercial agreement with large pharma
- New commercial agreement with AstraZeneca
- US and EU patents for innovative CellKeepâ„¢ slide
- Parsortix HER2 assay showcased at AACR 2024
- Parsortix at European breast cancer conference
- Potential utility in precision oncology
- Standard form for notification of major holdings
- Breakthrough clinical results
- Contract announcement with Eisai Inc.
More ▼
Key statistics
On Monday, Angle PLC (ANPCF:QXE) closed at 0.161, 21.97% above the 52 week low of 0.132 set on Aug 24, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 0.161 |
Average volume | -- |
---|---|
Shares outstanding | 260.58m |
Free float | 232.60m |
P/E (TTM) | -- |
Market cap | 50.81m GBP |
EPS (TTM) | -0.086 GBP |
Data delayed at least 15 minutes, as of Apr 29 2024.
More ▼